Kazuki Kato

Kazuki Kato

Auto-generated profile, based on publicly available information

Kazuki Kato

Mechanistic Immunology Research Unit, Institute of Integrated Research, Institute of Science Tokyo, 1-5-45 Yushima, Bunkyo-ku, Tokyo, Japan

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 September 2023 in Science Advances
Verified
Journal Article
Open access
KJKaiyi Jiang
Kaiyi Jiang
JLJustin Lim
Justin Lim
SSSamantha Sgrizzi
Samantha Sgrizzi
MTMichael Trinh
Michael Trinh
AKAlisan Kayabolen
Alisan Kayabolen
OAOmar O. Abudayyeh
Omar O. Abudayyeh
Programmable RNA-guided DNA nucleases perform numerous roles in prokaryotes, but the extent of their spread outside prokaryotes is unclear. Fanzors, the eukaryotic homolog of prokaryotic TnpB proteins, have been detected in genomes of eukaryotes and large viruses, but their activity and functions in eukaryotes remain unknown. Here, we characterize Fanzors as RNA-programmable DNA endonucleases, using biochemical and cellular evidence. We found diverse Fanzors that frequently associate with various eukaryotic transposases. Reconstruction of Fanzors evolution revealed multiple radiations of RuvC-containing TnpB homologs in eukaryotes. Fanzor genes captured introns and proteins acquired nuclear localization signals, indicating extensive, long-term adaptation to functioning in eukaryotic cells. Fanzor nucleases contain a rearranged catalytic site of the RuvC domain, similar to a distinct subset of TnpBs, and lack collateral cleavage activity. We demonstrate that Fanzors can be harnessed for genome editing in human cells, highlighting the potential of these widespread eukaryotic RNA-guided nucleases for biotechnology applications.

25 November 2022 in Science
Verified
Journal Article
Closed access
KKKazuki Kato
Kazuki Kato
SOSae Okazaki
Sae Okazaki
CSCian Schmitt-Ulms
Cian Schmitt-Ulms
KJKaiyi Jiang
Kaiyi Jiang
WZWenyuan Zhou
Wenyuan Zhou
HNHiroshi Nishimasu
Hiroshi Nishimasu
The type III-E CRISPR–Cas7-11 effector binds a CRISPR RNA (crRNA) and the putative protease Csx29 and catalyzes crRNA-guided RNA cleavage. We report cryo–electron microscopy structures of the Cas7-11–crRNA–Csx29 complex with and without target RNA (tgRNA), and demonstrate that tgRNA binding induces conformational changes in Csx29. Biochemical experiments revealed tgRNA-dependent cleavage of the accessory protein Csx30 by Csx29. Reconstitution of the system in bacteria showed that Csx30 cleavage yields toxic protein fragments that cause growth arrest, which is regulated by Csx31. Csx30 binds Csx31 and the associated sigma factor RpoE (RNA polymerase, extracytoplasmic E), suggesting that Csx30-mediated RpoE inhibition modulates the cellular response to infection. We engineered the Cas7-11–Csx29–Csx30 system for programmable RNA sensing in mammalian cells. Overall, the Cas7-11–Csx29 effector is an RNA-dependent nuclease-protease.

11 April 2025 in Nature Structural & Molecular Biology
Verified
Journal Article
Closed access
PDF file
JIJunichiro Ishikawa
Junichiro Ishikawa
KKKazuki Kato
Kazuki Kato
SKSoumya Kannan
Soumya Kannan
SOSae Okazaki
Sae Okazaki
SISoh Ishiguro
Soh Ishiguro
HNHiroshi Nishimasu
Hiroshi Nishimasu

30 January 2026 in Nature Structural & Molecular Biology
Verified
Journal Article
Closed access
PDF file
NNNaoto Nagahata
Naoto Nagahata
KKKazuki Kato
Kazuki Kato
SYSota Yamada
Sota Yamada
SKSoumya Kannan
Soumya Kannan
SOSae Okazaki
Sae Okazaki
HNHiroshi Nishimasu
Hiroshi Nishimasu

24 June 2026 in Nature Communications
Verified
Journal Article
Open access
YMYoshihisa Mitsuda
Yoshihisa Mitsuda
MSMaki Sugaya
Maki Sugaya
JIJunichiro Ishikawa
Junichiro Ishikawa
NNNaoto Nagahata
Naoto Nagahata
SOSae Okazaki
Sae Okazaki
HNHiroshi Nishimasu
Hiroshi Nishimasu
The type III-D2 CRISPR-Cas system comprises multiple Cas subunits and a CRISPR RNA, and is likely an evolutionary intermediate between the well-studied type III-A and III-E systems. Here we show that the type III-D2 complex synthesizes two distinct second messengers, SAM-AMP and SAM-AMP2, from S-adenosylmethionine (SAM) and ATP in response to target RNA recognition. We determined cryo-electron microscopy structures of the type III-D2 effector complex in different functional states, providing mechanistic insights into target RNA cleavage and second messenger synthesis. The structures reveal how SAM and ATP are recognized by the Cas10 subunit within the effector complex. Furthermore, our biological data suggest that both SAM-AMP and SAM-AMP2 act on the CorA ancillary effector, inducing growth arrest of infected bacterial cells and thereby conferring immunity. Thus, our study establishes the type III-D2 system as a unique anti-phage defense mechanism that employs both SAM-AMP and SAM-AMP2 as second messengers, expanding the repertoire of second messenger strategies in bacterial defense systems and highlighting the remarkable functional diversity of CRISPR-Cas systems.

29 December 2025 in Angewandte Chemie International Edition
Verified
Journal Article
Open access
DKDaiki Kanayama
Daiki Kanayama
NTNaohiro Terasaka
Naohiro Terasaka
KKKazuki Kato
Kazuki Kato
SOSae Okazaki
Sae Okazaki
HSHiroaki Suga
Hiroaki Suga
Nonviral protein vehicles for RNA delivery hold significant promises for various biotechnological applications due to their scalability, ease of engineering, and high biocompatibility. Directed evolution is a powerful approach to enhance protein activity, yet few nonviral protein vehicles have been evolved due to the challenges in linking genotype and phenotype. Here, we report engineering and directed evolution of a neo‐nucleocapsid enabling receptor‐specific RNA delivery. We applied the DogTag/DogCatcher protein ligation system to an artificial nucleocapsid and conducted directed evolution to obtain nucleocapsid displaying proteins. To create designer neo‐nucleocapsids, we lasso‐grafted a pharmacophore sequence of a pseudo‐cyclic peptide binding to the hepatocyte growth factor receptor MET into the loop of DogCatcher. After the cellular‐based directed evolution, endocytic uptake of neo‐nucleocapsids was improved whereas cytosolic release and subsequent protein expression from the delivered RNA were not detected. This experimental approach provides a versatile system for constructing protein cages delivering various cargos to specific cells.